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Abstract Specific transport between secretory compartments
requires that vesicular carriers contain targeting proteins known
as SNAREs. Ten v-SNAREs have been identified in the genome
of the yeast Saccharomyces cerevisiae by sequence analysis. We
report here the characterization of Gos1p, a v-SNARE localized
to the Golgi compartment and likely homolog of the mammalian
protein GOS-28/GS28. Gos1p is a type II membrane protein
with characteristic SNARE sequence hallmarks and is function-
ally a SNARE protein. Gos1p was originally identified as a 28
kDa protein in an immunoprecipitate of the cis-Golgi t-SNARE
Sed5p. This interaction between Sed5p and Gos1p is direct as
demonstrated by in vitro binding with recombinant proteins.
Deletion of GOS1 results in viable haploids with modest growth
and secretory defects. Close examination of the secretory
phenotype of GOS1-disrupted cells suggests that Gos1p may
play a role in multiple transport steps, specifically ER-Golgi and/
or intra-Golgi transport.
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1. Introduction
Sequestration of enzymatic activities into discrete compart-
ments is a hallmark of the eukaryotic cell. The secretory path-
way accomplishes this task by the vectorial transport of vesic-
ular carriers from the point of entry into the secretory
pathway, the endoplasmic reticulum, through the Golgi
stacks, to various ¢nal destinations in the cell such as the
plasma membrane. A picture of the molecular events involved
in vesicular transport has emerged over the last few years [1^
4]. Key amongst recent observations was the identi¢cation of
a protein family responsible for targeted fusion of transport
vesicles [5^9]. The original members of this increasing large
family were identi¢ed as the membrane proteins responsible
for recruiting the general transport factors N-ethylmaleimide
sensitive factor (NSF) and soluble NSF attachment protein
(SNAP) to their site of action, the membrane [5]. Based on
these interactions, the protein family was termed SNAP re-
ceptors (SNAREs). Two classes of SNAREs, v- and t-
SNAREs, have been identi¢ed, whose individual members
are localized to distinct intracellular compartments. Cognate
v- and t-SNAREs on opposing membranes pair a transport
vesicle with its target membrane for fusion [10]. Recent experi-
ments reconstituting SNAREs into liposomes have provided
evidence that SNAREs themselves are su⁄cient to mediate
lipid bilayer fusion [11].
The completed genome of Saccharomyces cerevisiae has so
far revealed a total of 18 SNARE proteins readily identi¢able
by sequence analysis [12^14]. Seven of the 10 known v-
SNAREs interact with the t-SNARE Sed5p in one fashion
or another [12,15^18]. Immunoprecipitation of Sed5p under
conditions of Sec18p inactivation resulted in the co-precipita-
tion of six of these seven [19]. We report here the character-
ization of Gos1p, the ¢nal member of this complex. Gos1p
directly interacts with Sed5p, is localized primarily to the
Golgi complex, and likely functions in endoplasmic reticulum
(ER)-Golgi and/or intra-Golgi transport.
2. Materials and methods
2.1. Strains and growth conditions
Yeast strains were routinely maintained in rich medium (YPD; 1%
yeast extract, 2% peptone, 2% dextrose) or synthetic complete medium
for plasmid maintenance (SCD; 0.67% yeast nitrogen base (Difco),
2% dextrose) with the appropriate nutritional supplements for auxo-
trophic requirements (Bu¡er Rad). Expression from the GAL1-10
promoter was induced by the addition of 2% galactose. The yeast
strains W3031A, W3031B, RSY271 [20], MSY42 (MATa/K ade2-1/
ade2-1 leu2-3,112/leu2-3,112 ura3-1/ura3-1 trp1-1/trp1-1 his3-11,15/
his3-11,15 can1-100/can1-100, GOS1: :HIS3/GOS1), MSY62 (MATK
ade2-1 leu2-3,112 ura3-1 trp1-1 his3-11,15 can1-100, GOS1: :HIS3),
and JCY1 (MATK ade2-1 leu2-3,112 ura3-1 trp1-1 his3-11,15 can1-
100, GOS1: :URA3) were used in this study.
2.2. Plasmids and DNA methods
Standard DNA manipulations [21] were performed in Escherichia
coli strain DH5K unless otherwise noted. Oligonucleotide sequences
used in this report are available upon request. The bacterial expres-
sion plasmids pMS141 (Gos1pvC-His6), pJM22 (GST-Sed5p),
pJM212 (GST-Gos1p), and pGEX-SEC17 (GST-Sec17p) were made
by amplifying the respective coding regions by PCR and ligating into
the pET3a (Novagen) based vector pMS/His [19] (pMS141), or
pGEX-2T. All are full length with the exception of pMS141 which
lacks the transmembrane domain and encodes amino acids 1^202 of
Gos1p. The mammalian cell expression vector pJM192 (myc-Gos1p)
was constructed in pcDNA3 (Invitrogen).
2.3. GOS1 disruption
Standard genetic procedures were performed according to Guthrie
and Fink [22]. The GOS1 locus was disrupted with the HIS3 gene in
the diploid strain W303. PCR fragments containing 5P and 3P non-
coding regions of GOS1 interrupted with the HIS3 gene were as-
sembled in pBluescript II (Stratagene) to generate a disruption con-
struct (pMS196). The diploid strain W303 was transformed with a
linear fragment from pMS196 generating MSY42. Integration at the
GOS1 locus was con¢rmed by Southern blotting. MSY62 is an
K-spore derived from MSY42.
The GOS1 gene was independently disrupted by the URA3 gene. A
fragment containing the GOS1 ORF was ampli¢ed by PCR and li-
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gated into pUC19 (New England Biolabs) generating pUCGOS1. A
fragment containing 133 bp upstream of the GOS1 ATG start site
through 60 bp from the translational stop site was removed from
pUCGOS1 and replaced with a 1 kb URA3 DNA fragment from
YDp-U [23] (pUCGOS1: :URA3). A linear fragment from pUCGO-
S1: :URA3 was used to transform diploid W303. Uracil prototrophs
were isolated and integration at the GOS1 locus was con¢rmed by
Southern blotting.
2.4. Sequence analysis
The multiple sequence alignment was performed as described [20].
The sequences are S. cerevisiae chromosome VIII ORF YHL031c,
Schizosaccharomyces pombe ORF C4G8.10 (Z56276), Arabidopsis
thaliana ORF (AC002387), Cricetulus griseus GOS-28 [24], Rattus
norvegicus GS28 [25], and amino acids 1289^1521 of the predicted
ORF F08F8.4 (U28991) from Caenorhabditis elegans chromosome
III. This ORF is predicted to encode a 1741 amino acid protein
translated from 28 exons. The region of similarity to Gos1p is en-
coded by exons 19^24. If exon 24 is translated past the proposed
boundary by 35 bp, an additional 11 amino acids are created before
an in frame stop codon is encountered. It is likely that this conceptual
ORF combines the GOS1 gene with another gene upstream.
2.5. Expression and puri¢cation of recombinant proteins
Recombinant, His6-tagged Gos1p was puri¢ed from inclusion
bodies in E. coli (BL21(DE3)) expressing pMS141 using nickel-NTA
agarose according to the manufacturer’s instructions. Full-length pro-
teins (GST-Sed5p, GST-Gos1p and GST-Sec17p) were prepared using
glutathione agarose beads. DH5K cells expressing the appropriate
plasmid were grown at 37‡C to an OD600 of V0.8, then induced by
the addition of IPTG to 1 mM for an additional 4 h. The induced
cells were harvested by centrifugation and resuspended in breaking
bu¡er A (25 mM HEPES-KOH pH 7.4, 300 mM KCl, 1 mM DTT,
and protease inhibitors) followed by the addition of Triton X-100 to
4% (w/v). GST-Sec17p expressing cells were lysed in the absence of
detergent. The cells were disrupted in a French press and the extract
cleared by centrifugation.
The GST-Gos1p fusion protein was further puri¢ed and cleaved
with thrombin. A 1.0 ml reaction containing 100 Wl of GST-Gos1p
extract, 60 Wl of a 50% slurry of glutathione beads and 840 Wl ‘GST
binding bu¡er’ (25 mM HEPES-KOH pH 7.4, 100 mM KCl, 1 mM
DTT, 0.5% (w/v) Triton X-100) was incubated at 4‡C for 30 min on a
rotating wheel. The beads were washed, resuspended in 100 Wl of
GST-binding bu¡er, and 10 units of thrombin (Sigma) was added
for 1 h at room temperature. Thrombin was removed by benzamidine
beads (Pharmacia) according to the manufacturer’s instructions.
2.6. Analysis of CPY transport: CPY pulse/chase and steady-state
immunoprecipitation
CPY immunoprecipitation was performed as described [26] with
slight modi¢cations. Lysed cells were preincubated with 50 Wl of pre-
clean agarose (Sigma) for 30 min at 4‡C in Tween 20-IP/BSA bu¡er
(50 mM Tris-HCl; pH 7.5, 0.1 mM EDTA, 150 mM NaCl, 0.5%
Tween 20, 10 mg/ml of BSA). The beads were removed and the super-
natant was incubated with a⁄nity-puri¢ed anti-CPY antibodies (6 Wg)
overnight at 4‡C with gentle shaking. Protein A-sepharose CL-4B
(7 mg) was later added to the suspension and incubated for a addi-
tional 2 h at 4‡C. The beads were collected by centrifugation, washed
twice in Tween 20-urea bu¡er (100 mM Tris-HCl; pH 7.5, 200 mM
NaCl, 2 M urea and 0.5% Tween 20), once in Tween 20-IP bu¡er and
once in TBS. 50 Wl of gel loading bu¡er (2U) was added, heated at
100‡C for 3 min and the supernatant was loaded onto a 7.5% SDS-
PAGE gel.
Steady-state CPY immunoprecipitations were performed essentially
as described [27]. RSY271 (two cultures) or MSY62 were inoculated
to 0.5 OD600/ml and grown at 25‡C and 30‡C respectively for 5 h.
Then one of the RSY271 (sec18-1) cultures was shifted to 37‡C and all
cultures continued to grow for an additional 1 h. 20 OD600 units were
harvested by centrifugation, resuspended in 300 Wl of 1% SDS and
lysed in the presence of 0.3 g of acid-washed glass beads by two 45 s
bursts on a vortexer. The extract was heated at 80‡C for 5 min fol-
lowed by the addition of 700 Wl of IP bu¡er (10 mM Tris-HCl pH 7.4,
2 mM EDTA, 0.1% Triton X-100). The extract was cleared by cen-
trifugation and CPY was immunoprecipitated with polyclonal CPY
antiserum. Immune complexes were recovered with protein G agarose
and were washed with IP bu¡er containing 0.1% SDS. The beads were
¢nally resuspended in 50 Wl of sample bu¡er. Twenty percent of each
precipitate was loaded onto a 7.5% SDS-PAGE gel.
2.7. Immuno£uorescence of Gos1p in HeLa cells
HeLa cells were grown on coverslips to 40% con£uence and trans-
fected with 1.5 Wg GOS1 DNA using SuperFect reagent (Qiagen)
according to the manufacturer’s instructions. In preparation for mi-
croscopy, the cells were washed twice with PBS and ¢xed with 4%
paraformaldehyde for 15 min, then permeabilized with 0.1% Triton
X-100 in PBS for 5 min, washed twice with PBS to remove detergent,
and blocked with 0.2% gelatin (Bio-Rad) in PBS for 1 h. The mono-
clonal antibody 9E10 [28], directed against the myc tag of Gos1p, was
diluted 1:1000 in gelatin/PBS (V5 Wg/ml IgG). A⁄nity-puri¢ed rabbit
polyclonal antibody to GOS-28 (0.2 mg/ml) [24] was diluted 1:2000 in
gelatin/PBS. The permeabilized cells were incubated with both anti-
bodies for 1 h, washed with gelatin/PBS and incubated with secondary
antibodies (Texas red-X goat anti-rabbit IgG conjugate and Oregon
Green 488 goat anti-mouse IgG conjugate, Molecular Probes), diluted
1:500 in gelatin/PBS, for 30 min. The coverslips were then washed and
mounted with Gelvatol [29]. Cells were analyzed on a Zeiss Axioplan
microscope equipped with a 63U/1.3 NA oil-immersion objective and
£uorescein and Texas red ¢lter sets.
2.8. In vitro binding reactions
GST-Sed5p was bound to beads in a reaction containing 100 Wl
GST-Sed5p bacterial extract (V50 Wg GST-Sed5p), 200 Wl of a 50%
slurry of glutathione beads and 700 Wl GST binding bu¡er. A control
reaction contained 50 Wl GST bacterial extract (V50 Wg GST). The
reactions were incubated at 4‡C for 30 min on a rotating wheel, then
pelleted by centrifugation. The beads were washed then resuspended
in GST binding bu¡er for a ¢nal volume including the beads of 1 ml.
The GST-Sed5p bound beads were aliquoted in 50 Wl aliquots (V2.5
Wg GST-Sed5p) and used in a binding reaction. Cleaved Gos1p was
added to individual GST-Sed5p aliquots in increasing amount and
GST binding bu¡er containing 0.5 mg/ml soybean trypsin inhibitor,
2 mM 4-(2-aminoethyl)benzenesulfonyl£uoride] (AEBSF, Calbio-
chem), and 10 mM benzamidine was added to a ¢nal volume of
100 Wl. The ¢nal concentrations of the reactants were V350 nM
GST-Sed5p, and 0 nM, 65 nM, 200 nM, 650 nM, 2 WM, and 6 WM
Gos1p respectively. The samples were incubated at 25‡C for 1 h, then
the beads were washed with GST binding bu¡er and the bound pro-
teins were eluted in 2USDS sample bu¡er.
SNARE proteins in the salt-washed detergent extract were isolated
by binding to GST-Sec17p beads. GST-Sec17p was bound to beads as
described above, washed with GST binding bu¡er containing 250 mM
KCl and aliquoted (V2.5 Wg per reaction). GST-Sec17p beads or
control glutathione beads without GST-Sec17p were incubated with
V350 Wg of salt-washed detergent extract in a ¢nal reaction volume
of 1.0 ml for 1 h at 4‡C. The beads were washed and the bound
proteins were eluted in 2USDS sample bu¡er and resolved by SDS-
PAGE.
3. Results
3.1. Gos1p is a yeast homolog of the SNARE protein
GOS-28/GS28
Inactivation of Sec18p (yeast NSF) results in the accumu-
lation of a distinct set of complexes containing the Golgi
t-SNARE Sed5p [19]. Components of these complexes are
the characterized ER-Golgi v-SNAREs Sec22p, Bet1p [30^
32], Bos1p [33,34], and Ykt6p [20]. Additional proteins iden-
ti¢ed in this complex with sequence properties characteristic
of v-SNAREs were proteins of 14 (p14) and 28 (p28) kDa.
p14 was independently identi¢ed as Sft1p (suppressor of sed5
ts) by Ban¢eld and colleagues [17] as a high copy number
suppressor of a temperature sensitive allele of Sed5p. We
recently reported the identity of the ¢nal component of this
complex, p28, as the 25 kDa open reading frame YHL031c
which we proposed be named Gos1p (Golgi SNARE) [20].
Analysis of the Gos1p primary sequence indicates a modest
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similarity to the mammalian Golgi SNARE GOS-28/GS28.
The overall sequence identity of Gos1p with GOS-28 is
27.6% and is spread throughout the entire sequence. A
BLAST search using GOS-28 as the query sequence against
the translated ORFs of the complete S. cerevisiae genome
identi¢ed Gos1p as the only statistically signi¢cant match
(P6 6.7U10318). This observation suggests that Gos1p is
the yeast homolog of GOS-28/GS28. Additional BLAST
searches with Gos1p as the query sequence reveal potential
homologs in ¢ssion yeast (S. pombe, 33% identity), plants
(A. thaliana, 27% identity), and the nematode (C. elegans,
27% identity).
In addition to sequence similarity to GOS-28, Gos1p also
contains predicted secondary structures characteristic of
SNARE proteins. Coiled-coil structures are often found in
SNARE proteins and Gos1p contains a region (amino acids
135^160) with a 60% propensity to from a coiled coil as pre-
dicted by the Lupas algorithm [35]. Hydropathy analysis by
the method of Kyte and Doolittle [36] indicates that Gos1p
has a carboxy-terminal membrane anchor characteristic of
most synaptobrevin and syntaxin-like SNARE proteins, with
the exception of Ykt6p and its homologs. Indeed, incubation
of cellular membranes with 1 M NaCl, or 0.1 M Na3CO2, pH
11, demonstrates that Gos1p is tightly associated with mem-
branes. Only the treatment that solubilizes membranes (1%
Triton X-100) releases Gos1p from the membrane showing
that it is has properties of an integral membrane protein
(data not shown).
SNARE proteins interact with SNAP, either alone or when
complexed to its cognate partner(s) in the case of v-SNAREs.
Gos1p, likely complexed to a t-SNARE in the detergent ex-
tract, does bind to the yeast equivalent of K-SNAP, Sec17p
(Fig. 1A). GST-Sec17p was bound to glutathione agarose and
incubated with a salt-washed Triton X-100 extract of total
yeast membranes. Fig. 1A shows that Gos1p is present in
the detergent extract (lane 1) and is able to bind to the beads
only when GST-Sec17p is present (lane 3 vs. lane 2). Sec22p,
a well characterized v-SNARE, behaves in an identical
manner. Conversely, the rab protein Ypt1p is found in the
extract but does not bind to the beads with or without
GST-Sec17p.
3.2. Gos1p associates directly with Sed5p
Since Gos1p was found in an immunoprecipitate with
Sed5p, we wanted to determine if this interaction was the
result of a direct association of Sed5p and Gos1p. To answer
this question, we performed pairwise binding assays with re-
combinant proteins. Both full-length Sed5p and full-length
Gos1p were expressed as glutathione S-transferase (GST) fu-
sion proteins in E. coli. Both proteins were soluble, highly
expressed and could be released from GST by thrombin cleav-
age and were therefore available as both fusion proteins and
the free proteins. Full-length Gos1p binds, in a saturable man-
ner, to GST-Sed5p (Fig. 1B). The reciprocal interaction is also
possible (data not shown). The interactions are speci¢c since
neither Gos1p nor Sed5p binds appreciably to GST alone.
These experiments demonstrate that Gos1p and Sed5p are
capable of forming a direct association which is consistent
with their co-immunoprecipitation with the Sed5p antibody.
3.3. Disruption of the GOS1 locus has minor e¡ects
on cell growth
In an e¡ort to de¢ne the function of Gos1p, the GOS1 gene
was disrupted in the W303 diploid (HIS3 gene in MSY42 and
URA3 in JCY1, Fig. 2). Sporulation and analysis of the re-
sulting tetrads revealed that GOS1 was not an essential gene.
All four haploid progeny were viable at 25‡C (Fig. 2B). In-
terestingly, when spores were germinated at 37‡C, the dis-
rupted spores failed to germinate (Fig. 2B, 37‡C). This may
indicate that Gos1p serves an essential function in germina-
tion, but is dispensable for vegetative growth. Haploids ger-
minated at 25‡C were capable of near wild-type growth at
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Fig. 2. Cells lacking the GOS1 gene are viable. A: Growth of wild-
type (W3031B) or GOS1v strain (MSY62) at 30‡C in rich medium.
Both strains were inoculated at V0.1 OD600/ml and sample taken
at 1 h intervals. Each point represents three independent measure-
ments. B: Tetrad analysis. The indicated diploid was sporulated and
tetrads dissected. The resulting spores were germinated and grown
at the indicated temperature.
Fig. 1. Gos1p binds to GST-Sed5p and GST-Sec17p in vitro. A:
Gos1p, present in a detergent extract, binds to GST-Sec17p. Lane
1: Approximately 3.5 Wg of total yeast membrane extract. Gluta-
thione agarose beads with (lane 3) or without (lane 2) V2.5 Wg
GST-Sec17p were incubated with V350 Wg total yeast membrane
extract, washed and eluted with sample bu¡er. Lanes 2 and 3 repre-
sent 20% of the total reaction volume. The samples were resolved
by SDS-PAGE and immunoblotted with antibodies to Gos1p
(1:2000), Sec22p (1:1000), Ypt1p (1:1000). B: Gos1p binds to
Sed5p. Approximately 2.5 Wg of GST-Sed5p was bound to gluta-
thione agarose as described in Section 2. The indicated amounts of
Gos1p were added to the GST-Sed5p beads and the amount of
Gos1p bound was determined. The samples were resolved by SDS-
PAGE, transferred to nitrocellulose and immunoblotted with an
anti-Gos1p antibody.
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25‡C in all media tested including ra⁄nose, galactose, glucose,
ethanol, glycerol, acetate, and glucose at 37‡C (data not
shown). A slight growth reduction of approximately 25%
was observed in rich glucose medium at 25‡C (doubling
time of 84 min vs. 112 min in YPD, Fig. 2A).
3.4. Electron microscopic analysis of the GOS1 disruption
Consistent with the absence of a strong growth defect,
many of the GOS1-disrupted cells appear morphologically
normal; however, 10^20% of cells possessed a variety of aber-
rant structures (Fig. 3). This heterogeneity could depend on
the visible section within a cell or might be inherent to distinct
cell cycle stages or growth phases. Defects ranged from frag-
mentation of the vacuole, a common occurrence in secretory
defects, to substantial accumulation of membranes in some
cells (Fig. 3B, inset). These exaggerated membranes are sim-
ilar in appearance to the ER membranes that accumulate in
mutants that are defective in ER-Golgi transport [20,37]. Ad-
ditionally, the darkly stained vesicular membranes seen in Fig.
3C (inset) are strikingly similar to those seen in the temper-
ature sensitive mutant of SFT1 [17]. Such structures have been
postulated to be abnormal Golgi remnants.
3.5. Gos1p may be involved in both ER-Golgi and intra-Golgi
transport
While growth appears relatively una¡ected by disruption of
the GOS1 gene, subtle e¡ects on secretory function may still
be occurring. To assess secretory function, the export of two
well characterized secretory markers, carboxypeptidase Y
(CPY, product of the PRC1 gene) and invertase (Suc2p),
was analyzed. The externalization of invertase activity was
compared in the wild-type strain W3031B and the isogenic
GOS1 disrupted strain MSY62. The absence of Gos1p had
little e¡ect on the appearance of external invertase activity
(data not shown).
While the overall secretion of invertase was roughly normal,
analysis of another well characterized secretory marker, the
soluble vacuolar hydrolase CPY, produced a di¡erent result.
CPY is translocated into the ER where it receives core oligo-
saccharide additions yielding the p1 form. These sugars are
further processed along the secretory pathway [38]. Extension
of the core sugars by the addition of K1,3-mannose residues in
the medial-Golgi results in the p2CPY precursor form [39^41].
Finally, p2CPY is proteolytically processed in the vacuole
resulting in the mature form of the enzyme. A pulse-chase
examination of CPY processing revealed that the overall
transit rate was slowed in the absence of Gos1p (Fig. 4A).
The most apparent kinetic e¡ect observed in the pulse-chase
analysis is an increased lifetime of the p1CPY precursor. This
e¡ect indicates a reduction in the rate of either ER to Golgi
transport or cis to medial intra-Golgi transport, or both. The
reduction in the amount of mature CPY and the loss in total
signal is readily explained by the secretion of the p2CPY
intermediate (Fig. 4C, see below).
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Fig. 3. Morphological analysis of GOS1v disrupted cells by electron microscopy. A: Wild-type cells (W3031B) were grown to OD600 V1.0,
stained with potassium permanganate and processed as previously described [20]. B and C: GOS1v cells (MSY62) were processed and in A.
The area of the cell depicted in the insets of B and C are indicated by the dashed box. The bar represents 500 nm.
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To test if the GOS1 deletion also a¡ects later transport
steps we analyzed CPY at steady-state. Cells were lysed in
the presence of SDS and all processing intermediates of
CPY were immunoprecipitated with a polyclonal CPY anti-
body. GOS1-disrupted cells show a distinct steady-state accu-
mulation of the p2CPY intermediate, with little p1CPY accu-
mulation (Fig. 4B, lane 3). Such a p2CPY accumulation
would not be expected, if the absence of Gos1p a¡ects only
early transport steps. For example, the sec18-1 strain, which
has an extremely rapid onset after shift to the restrictive tem-
perature [39], accumulates p1CPY, and has no or little e¡ect
on p2CPY. At the permissive temperature (Fig. 4B, lane 1),
the sec18-1 strain shows little accumulation of p1CPY similar
to wild-type controls (not shown). In contrast, the p2CPY
accumulation in the GOS1-disrupted strain MSY62 indicates
a role of Gos1p in later transport steps.
The strongest conclusions that can be drawn from these
data are that Gos1p has a clear role in the early secretory
pathway up to the medial-Golgi where the conversion of
p1CPY to p2CPY occurs. Gos1p may also function in later
intra-Golgi transport steps; however, it cannot be excluded
that these e¡ects might be a secondary consequence of the
earlier defects.
3.6. Gos1p co-localizes with GOS-28 in HeLa cells
The absence of Gos1p results in minor processing defects to
and within the Golgi apparatus. This information would sug-
gest the function of Gos1p was also within the Golgi. As
mentioned previously, Gos1p has a signi¢cant degree of ho-
mology with the mammalian intra-Golgi SNARE GOS-28/
GS28, which also suggests an intra-Golgi function for
Gos1p. Since the yeast Golgi is ill-de¢ned morphologically,
we chose to examine the localization of Gos1p in a mamma-
lian cell system. To this end, myc-tagged Gos1p was transi-
ently expressed in wild-type HeLa cells and its localization
relative to endogenous GOS-28/GS28 investigated. Fig. 5A
shows the previously described Golgi staining pattern of
GOS-28/GS28 [24,25,42]. When the localization of Gos1p is
determined in the same cells with the anti-myc antibody, a
clear co-localization is revealed (Fig. 5B). A Golgi staining
pattern is also observed when the distribution of Gos1p is
followed with a polyclonal Gos1p antibody (data not shown).
These results con¢rm that Gos1p is indeed localized identi-
cally to GOS-28/GS28 in the Golgi.
3.7. Cells lacking Gos1p abnormally secrete BiP and CPY
Gos1p localizes to the Golgi apparatus in HeLa cells and
manifests a minor defect in the late Golgi-localized processing
of CPY, manifested as a modest accumulation of the p2CPY
precursor. However, Gos1p was originally identi¢ed as an
interacting partner of the cis-Golgi t-SNARE Sed5p, and
has potential defects in ER-Golgi transport as well. One po-
tential explanation of these two initially con£icting observa-
tions is that Gos1p is involved in directing anterograde vesicle
to the Golgi apparatus from the ER and also participates in
directing retrograde transport vesicle from a later Golgi com-
partment back to the CGN/cis-Golgi where Sed5p receives it.
This latter role is similar to the function described for Sft1p,
which was also found in the Sed5p immunoprecipitate. A
temperature sensitive mutation in Sft1p also manifests defects
in later Golgi enzyme processing. Hypersecretion of ER-resi-
dent proteins such as BiP (Kar2p) has been suggested to be an
indirect measure of a defect in retrograde directed vesicles
(ER retention defective, erd phenotype) [43]. sft1-1 has an
erd phenotype as does an allele of Sec22p (sec22-3), a
v-SNARE known to be involved in ER-Golgi transport [17].
Recently, a more direct demonstration of Sec22p function in
retrograde transport from the Golgi back to the ER was re-
vealed as Sec22p can be immunoprecipitated with the ER-
localized t-SNARE Ufe1p [44]. Since Gos1p is poised to be
a retrograde v-SNARE similar to Sft1p, we determined if the
GOS1 deletion also showed an erd phenotype. Wild-type cells
and vGOS1 cells were back diluted into fresh medium and
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Fig. 5. Immuno£uorescence of HeLa cells expressing yeast Gos1p.
A: Transfected HeLa cells expressing mycGos1p immunodecorated
with GOS-28 antisera [24]. B: Gos1p co-localized in the same ¢eld
of cell with the 9E10 monoclonal anti-myc antibody.
Fig. 4. Intracellular processing of carboxypeptidase Y in wild-type
and GOS1v cells. A: JCY1 cells were pulse labeled with
[35S]methionine for 10 min and chased for the indicated times at
25‡C. The cells were lysed, CPY immunoprecipitated, and proteins
resolved by SDS-PAGE. B: CPY was immunoprecipitated from the
sec18-1 strain (RSY271) and the GOS1v strain (MSY62) as de-
scribed in Section 2. The immunoprecipitates were resolved by SDS-
PAGE on a 7.5% gel and immunobotted with a monoclonal CPY
antibody (10A5-B5 1:1000, Molecular Probes). C: Wild-type cells
(W3031A) or GOS1v cells (MSY62) were back diluted into fresh
YPD medium to an OD600 of 0.1. The cells were grown at 30‡C
and 1 ml aliquots removed at the indicated time intervals. The cells
were separated from the medium by centrifugation and proteins in
the medium were precipitated by the addition of 10% TCA. The
medium proteins were resolved by SDS-PAGE and immunoblotted
with a polyclonal antiserum to Kar2p (BiP 1:1000) or the monoclo-
nal CPY antibody (10A5-B5 1:1000).
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followed over time. Proteins secreted into the medium were
precipitated with TCA and resolved by SDS-PAGE. Fig. 4C
shows that GOS1v cells secreted roughly ¢ve-fold more BiP
than wild-type cells, con¢rming an erd phenotype. These sam-
ples were also assayed for secretion of CPY. Indeed the
p2CPY intermediate was secreted well above wild-type levels.
4. Discussion
This work describes the characterization of the S. cerevisiae
SNARE Gos1p. Gos1p is an integral membrane protein with
a C-terminal membrane anchor, and a region with a strong
propensity to form coiled-coils. Gos1p interacts directly and
speci¢cally with the Golgi t-SNARE Sed5p, and when com-
plexed with Sed5p, binds Sec17p, the yeast SNAP homolog
(Fig. 1).
Sporulation of tetrads carrying a single disruption of the
GOS1 locus produce viable progeny at 25‡C. Interestingly,
when spores were grown at 37‡C, the disrupted spores fail
to germinate (Fig. 2). Haploid GOS1 disruptants germinated
at 25‡C displayed a modest growth reduction, manifested as
V25% increase in generation time, abnormal membranous
structure and vacuolar fragmentation (Fig. 3). While the ab-
sence of Gos1p marginally slowed cell growth, overexpression
of Gos1p 10^20-fold, under the control of the strong galactose
promoter, has no detectable e¡ect on growth (data not
shown). Close examination of the GOS1v cells show clear
secretory defects. The processing of carboxypeptidase Y is
slowed such that both the p1CPY and p2CPY intermediates
accumulate. Additionally, high levels of the ER resident pro-
tein BiP are secreted, suggestive of an ER-retention defective
(erd) phenotype (Fig. 4).
Gos1p likely participates in more than one transport step.
Gos1p action in ER to Golgi transport or cis to medial intra-
Golgi transport, or both, is indicated by the slowed kinetics of
p1CPY processing. The increased secretion of BiP could also
suggest a defect in retrograde transport from or within the
Golgi. Evidence of a later role in the secretory pathway de-
rives from a slight steady-state accumulation of p2CPY pre-
cursors and the secretion of p2CPY. However, while kinetic
analysis does not discriminate between these two transport
steps, the clear localization of Gos1p to the Golgi suggests
that its role as a SNARE may be limited to transport within
this organelle. Defects in later transport steps may be a con-
sequence of an additional site of Gos1p action; however, sec-
ondary e¡ects cannot be excluded. The secretion of p2CPY is
somewhat puzzling but may be explained by a reduced steady
state or a partial mislocalization of the CPY sorting receptor,
Vps10p, which shuttles between the trans-Golgi and the pre-
vacuolar/late endosomal compartment [45].
A v-SNARE functioning at multiple transport step is not
without precedence [12,13,18]. In addition to the interaction
between Gos1p and Sed5p, Gos1p might interact with other
t-SNAREs. Another possibility would be that Gos1p in com-
bination with other v-SNAREs may direct bi-directional ER-
Golgi and intra-Golgi. Finally, it is possible that Gos1p-Sed5p
interactions occur throughout the Golgi and that string pro-
teins like Uso1p ensure sequential transport within the Golgi.
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